Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer
Abstract Aim The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. Methods Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. Results Th...
Gespeichert in:
| Veröffentlicht in: | European journal of cancer (1990) 2007-05, Vol.43 (8), p.1300-1307 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1307 |
|---|---|
| container_issue | 8 |
| container_start_page | 1300 |
| container_title | European journal of cancer (1990) |
| container_volume | 43 |
| creator | Suhonen, Kirsi A Anttila, Maarit A Sillanpää, Sari M Hämäläinen, Kirsi M Saarikoski, Seppo V Juhola, Matti Kosma, Veli-Matti |
| description | Abstract Aim The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. Methods Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. Results The Chalkley count was categorised into two groups according to the median value: low |
| doi_str_mv | 10.1016/j.ejca.2007.03.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70504847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0959804907001967</els_id><sourcerecordid>70504847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-9c747225b749be721dd086f4f1cb70933fcc2b34133db86c27496ac54545d26b3</originalsourceid><addsrcrecordid>eNp9kl2L1DAUhoso7rj6B7yQ3Ohd68lHmxZEWAa_YEFEvQ5pejqTbiYZk3Zh_r3pzsCCF5KLc5HnPSTPOUXxmkJFgTbvpwonoysGICvgVS5Pig1tZVdCW7OnxQa6uitbEN1V8SKlCTLRCnheXFEpRNvUfFPEH4v2sx2t0bMNnoSRaL-zYYcek02kP5F5j2S71-7O4YkccN6HITMDsXMixxh2PqTZGpLszj_08QaJ9QSPNied1Y6Eex2t9uThLr4sno3aJXx1qdfF78-ffm2_lrffv3zb3tyWRvBuLjsjhWSs7qXoepSMDgO0zShGanoJHeejMazngnI-9G1jWOYabWqRz8Canl8X78598yP_LJhmdbDJoHPaY1iSklCDaIXMIDuDJoaUIo7qGO1Bx5OioFbTalKrabWaVsBVLjn05tJ96Q84PEYuajPw9gLoZLQbY_68TY9cnhM0rM7chzOH2cW9xaiSsZhFDTaimdUQ7P_f8fGfuHHW5zG4OzxhmsISfbasqEpMgfq57sS6EiABaNdI_hfHU7JS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>70504847</pqid></control><display><type>article</type><title>Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Suhonen, Kirsi A ; Anttila, Maarit A ; Sillanpää, Sari M ; Hämäläinen, Kirsi M ; Saarikoski, Seppo V ; Juhola, Matti ; Kosma, Veli-Matti</creator><creatorcontrib>Suhonen, Kirsi A ; Anttila, Maarit A ; Sillanpää, Sari M ; Hämäläinen, Kirsi M ; Saarikoski, Seppo V ; Juhola, Matti ; Kosma, Veli-Matti</creatorcontrib><description>Abstract Aim The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. Methods Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. Results The Chalkley count was categorised into two groups according to the median value: low <8 or high ⩾8. The low Chalkley count correlated significantly with serous and clear cell histological subtype of the tumour ( p < 0.0005), whereas there existed no association with FIGO (International Federation of Gynecology and Obstetrics) stage, histological grade, presence of primary residual tumour, age at diagnosis, or chemotherapy response. In univariate analysis, the high Chalkley count predicted poor overall survival in the subgroup of patients with FIGO stages III–IV tumours ( p = 0.007) but not in the entire study cohort. However, in multivariate analysis, the Chalkley count was found to be an independent predictor of death from ovarian cancer in the entire study cohort ( p = 0.044, RR = 1.50, 95% CI 1.01–2.21) as well as in the subgroup of FIGO stages III–IV tumours ( p = 0.046, RR = 1.58, 95% CI 1.01–2.46) together with the presence of primary residual tumour ( p < 0.0005, RR = 5.10, 95% CI 3.02–8.62, and p = 0.002, RR = 4.28, 95% CI 1.34–13.73, respectively). Conclusions The Chalkley count seems to be suitable for evaluation of angiogenesis and to have prognostic significance in ovarian cancer.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2007.03.007</identifier><identifier>PMID: 17448653</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Adult ; Age of Onset ; Aged ; Aged, 80 and over ; Angiogenesis ; Antigens, CD34 - metabolism ; Biological and medical sciences ; CD34 ; Chalkley ; Disease-Free Survival ; Female ; Hematology, Oncology and Palliative Medicine ; Humans ; Immunohistochemistry ; Medical sciences ; Middle Aged ; Neovascularization, Pathologic - metabolism ; Neovascularization, Pathologic - pathology ; Ovarian cancer ; Ovarian Neoplasms - blood supply ; Ovarian Neoplasms - metabolism ; Pharmacology. Drug treatments ; Prognosis ; Survival ; Survival Analysis ; Tumors</subject><ispartof>European journal of cancer (1990), 2007-05, Vol.43 (8), p.1300-1307</ispartof><rights>Elsevier Ltd</rights><rights>2007 Elsevier Ltd</rights><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-9c747225b749be721dd086f4f1cb70933fcc2b34133db86c27496ac54545d26b3</citedby><cites>FETCH-LOGICAL-c439t-9c747225b749be721dd086f4f1cb70933fcc2b34133db86c27496ac54545d26b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0959804907001967$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18790625$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17448653$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suhonen, Kirsi A</creatorcontrib><creatorcontrib>Anttila, Maarit A</creatorcontrib><creatorcontrib>Sillanpää, Sari M</creatorcontrib><creatorcontrib>Hämäläinen, Kirsi M</creatorcontrib><creatorcontrib>Saarikoski, Seppo V</creatorcontrib><creatorcontrib>Juhola, Matti</creatorcontrib><creatorcontrib>Kosma, Veli-Matti</creatorcontrib><title>Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Abstract Aim The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. Methods Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. Results The Chalkley count was categorised into two groups according to the median value: low <8 or high ⩾8. The low Chalkley count correlated significantly with serous and clear cell histological subtype of the tumour ( p < 0.0005), whereas there existed no association with FIGO (International Federation of Gynecology and Obstetrics) stage, histological grade, presence of primary residual tumour, age at diagnosis, or chemotherapy response. In univariate analysis, the high Chalkley count predicted poor overall survival in the subgroup of patients with FIGO stages III–IV tumours ( p = 0.007) but not in the entire study cohort. However, in multivariate analysis, the Chalkley count was found to be an independent predictor of death from ovarian cancer in the entire study cohort ( p = 0.044, RR = 1.50, 95% CI 1.01–2.21) as well as in the subgroup of FIGO stages III–IV tumours ( p = 0.046, RR = 1.58, 95% CI 1.01–2.46) together with the presence of primary residual tumour ( p < 0.0005, RR = 5.10, 95% CI 3.02–8.62, and p = 0.002, RR = 4.28, 95% CI 1.34–13.73, respectively). Conclusions The Chalkley count seems to be suitable for evaluation of angiogenesis and to have prognostic significance in ovarian cancer.</description><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Angiogenesis</subject><subject>Antigens, CD34 - metabolism</subject><subject>Biological and medical sciences</subject><subject>CD34</subject><subject>Chalkley</subject><subject>Disease-Free Survival</subject><subject>Female</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Neovascularization, Pathologic - pathology</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - blood supply</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Pharmacology. Drug treatments</subject><subject>Prognosis</subject><subject>Survival</subject><subject>Survival Analysis</subject><subject>Tumors</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kl2L1DAUhoso7rj6B7yQ3Ohd68lHmxZEWAa_YEFEvQ5pejqTbiYZk3Zh_r3pzsCCF5KLc5HnPSTPOUXxmkJFgTbvpwonoysGICvgVS5Pig1tZVdCW7OnxQa6uitbEN1V8SKlCTLRCnheXFEpRNvUfFPEH4v2sx2t0bMNnoSRaL-zYYcek02kP5F5j2S71-7O4YkccN6HITMDsXMixxh2PqTZGpLszj_08QaJ9QSPNied1Y6Eex2t9uThLr4sno3aJXx1qdfF78-ffm2_lrffv3zb3tyWRvBuLjsjhWSs7qXoepSMDgO0zShGanoJHeejMazngnI-9G1jWOYabWqRz8Canl8X78598yP_LJhmdbDJoHPaY1iSklCDaIXMIDuDJoaUIo7qGO1Bx5OioFbTalKrabWaVsBVLjn05tJ96Q84PEYuajPw9gLoZLQbY_68TY9cnhM0rM7chzOH2cW9xaiSsZhFDTaimdUQ7P_f8fGfuHHW5zG4OzxhmsISfbasqEpMgfq57sS6EiABaNdI_hfHU7JS</recordid><startdate>20070501</startdate><enddate>20070501</enddate><creator>Suhonen, Kirsi A</creator><creator>Anttila, Maarit A</creator><creator>Sillanpää, Sari M</creator><creator>Hämäläinen, Kirsi M</creator><creator>Saarikoski, Seppo V</creator><creator>Juhola, Matti</creator><creator>Kosma, Veli-Matti</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20070501</creationdate><title>Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer</title><author>Suhonen, Kirsi A ; Anttila, Maarit A ; Sillanpää, Sari M ; Hämäläinen, Kirsi M ; Saarikoski, Seppo V ; Juhola, Matti ; Kosma, Veli-Matti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-9c747225b749be721dd086f4f1cb70933fcc2b34133db86c27496ac54545d26b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Angiogenesis</topic><topic>Antigens, CD34 - metabolism</topic><topic>Biological and medical sciences</topic><topic>CD34</topic><topic>Chalkley</topic><topic>Disease-Free Survival</topic><topic>Female</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Neovascularization, Pathologic - pathology</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - blood supply</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Pharmacology. Drug treatments</topic><topic>Prognosis</topic><topic>Survival</topic><topic>Survival Analysis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suhonen, Kirsi A</creatorcontrib><creatorcontrib>Anttila, Maarit A</creatorcontrib><creatorcontrib>Sillanpää, Sari M</creatorcontrib><creatorcontrib>Hämäläinen, Kirsi M</creatorcontrib><creatorcontrib>Saarikoski, Seppo V</creatorcontrib><creatorcontrib>Juhola, Matti</creatorcontrib><creatorcontrib>Kosma, Veli-Matti</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suhonen, Kirsi A</au><au>Anttila, Maarit A</au><au>Sillanpää, Sari M</au><au>Hämäläinen, Kirsi M</au><au>Saarikoski, Seppo V</au><au>Juhola, Matti</au><au>Kosma, Veli-Matti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2007-05-01</date><risdate>2007</risdate><volume>43</volume><issue>8</issue><spage>1300</spage><epage>1307</epage><pages>1300-1307</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Abstract Aim The aim of the present study was to clarify prognostic role of angiogenesis in epithelial ovarian cancer. Methods Quantification of angiogenesis was performed by the Chalkley method after immunostaining of 175 epithelial ovarian cancer specimens with an antibody against CD34. Results The Chalkley count was categorised into two groups according to the median value: low <8 or high ⩾8. The low Chalkley count correlated significantly with serous and clear cell histological subtype of the tumour ( p < 0.0005), whereas there existed no association with FIGO (International Federation of Gynecology and Obstetrics) stage, histological grade, presence of primary residual tumour, age at diagnosis, or chemotherapy response. In univariate analysis, the high Chalkley count predicted poor overall survival in the subgroup of patients with FIGO stages III–IV tumours ( p = 0.007) but not in the entire study cohort. However, in multivariate analysis, the Chalkley count was found to be an independent predictor of death from ovarian cancer in the entire study cohort ( p = 0.044, RR = 1.50, 95% CI 1.01–2.21) as well as in the subgroup of FIGO stages III–IV tumours ( p = 0.046, RR = 1.58, 95% CI 1.01–2.46) together with the presence of primary residual tumour ( p < 0.0005, RR = 5.10, 95% CI 3.02–8.62, and p = 0.002, RR = 4.28, 95% CI 1.34–13.73, respectively). Conclusions The Chalkley count seems to be suitable for evaluation of angiogenesis and to have prognostic significance in ovarian cancer.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>17448653</pmid><doi>10.1016/j.ejca.2007.03.007</doi><tpages>8</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-8049 |
| ispartof | European journal of cancer (1990), 2007-05, Vol.43 (8), p.1300-1307 |
| issn | 0959-8049 1879-0852 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70504847 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adult Age of Onset Aged Aged, 80 and over Angiogenesis Antigens, CD34 - metabolism Biological and medical sciences CD34 Chalkley Disease-Free Survival Female Hematology, Oncology and Palliative Medicine Humans Immunohistochemistry Medical sciences Middle Aged Neovascularization, Pathologic - metabolism Neovascularization, Pathologic - pathology Ovarian cancer Ovarian Neoplasms - blood supply Ovarian Neoplasms - metabolism Pharmacology. Drug treatments Prognosis Survival Survival Analysis Tumors |
| title | Quantification of angiogenesis by the Chalkley method and its prognostic significance in epithelial ovarian cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T21%3A30%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Quantification%20of%20angiogenesis%20by%20the%20Chalkley%20method%20and%20its%20prognostic%20significance%20in%20epithelial%20ovarian%20cancer&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Suhonen,%20Kirsi%20A&rft.date=2007-05-01&rft.volume=43&rft.issue=8&rft.spage=1300&rft.epage=1307&rft.pages=1300-1307&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2007.03.007&rft_dat=%3Cproquest_cross%3E70504847%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=70504847&rft_id=info:pmid/17448653&rft_els_id=1_s2_0_S0959804907001967&rfr_iscdi=true |